Clinical Trials Directory

Trials / Completed

CompletedNCT02414607

Effect of Elderberry Juice on Cognition and Inflammation in Patients With Mild Cognitive Impairment

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
24 (actual)
Sponsor
University of Missouri-Columbia · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

Elderberries (Sambuci fructus) have been shown in a number of studies to have significant anti-inflammatory and antioxidant effects. Multiple human and animal studies have supported the anti-inflammatory and antioxidant effects of elderberry preparations and it has been used in natural medicine for hundreds of years. Studies examining factors that may decrease the risk of Alzheimer's disease have revealed that drinking juices with similar properties to elderberries is one of the most reliable way to decrease risk. As such the investigators wish to determine the effects of elderberry juice on cognitive decline in a group of subjects at high risk for Alzheimer's disease, those with mild cognitive impairment. Elderberry juice is a commercially available nutritional supplement and easily available to this population.

Conditions

Interventions

TypeNameDescription
BIOLOGICALElderberry Juice
OTHERPlacebo

Timeline

Start date
2016-09-01
Primary completion
2019-12-01
Completion
2019-12-01
First posted
2015-04-13
Last updated
2022-06-23
Results posted
2022-06-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02414607. Inclusion in this directory is not an endorsement.